Scientists at KAIST have developed a groundbreaking method to convert colon cancer cells into healthy ones using a ...

Working with a line of colon cancer cells, Korean researchers figured out a way to throw a few genetic switches to cause the ...

KAIST researchers have developed new technology that can transform colon cancer cells into normal-like cells. Led by ...

A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...

The most-read articles focused on the new colonoscopy guidelines, the relationship between diabetes and colorectal cancer, ...

Amivantamab is under clinical development by Johnson & Johnson and currently in Phase III for Metastatic Colorectal Cancer.

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

Floats covered in flowers hit the streets for the annual Rose Parade. A cancer survivor from the Chicago area was on the City ...

A new publication from Genes & Diseases; DOI 10.1016/j.gendis.2024.101441, discusses how Ce6-GFFY is a novel photosensitizer for colorectal cancer therapy.

Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...